2024 and Myocardial Infarction - Cardiovascular Update

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

DAIC

JULY 10, 2024

mtaschetta-millane Wed, 07/10/2024 - 09:02 July 10, 2024 — CellProthera , a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia, Inc. ,

Myocardial Infarction

Myocardial Infarction Heart Failure Heart Attack Heart attacks

Association between waist-to-hip ratio and risk of myocardial infarction: a systematic evaluation and meta-analysis

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

Two researchers independently screened, extracted data, and assessed quality using the Newcastle-Ottawa Scale (NOS) and Revman5.3. Meta-analysis with Stata 16.0 calculated the combined Odd ratio (OR) for WHR and MI risk.

Myocardial Infarction

Myocardial Infarction Research

No benefit of apoA-I infusion after myocardial infarction

Nature Reviews - Cardiology

MAY 2, 2024

Nature Reviews Cardiology, Published online: 03 May 2024; doi:10.1038/s41569-024-01031-z In the AEGIS-II trial, infusion of apolipoprotein A-I to increase cholesterol efflux capacity did not improve outcomes in patients with acute myocardial infarction.

Myocardial Infarction

Myocardial Infarction Cholesterol Outcomes

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Case 34-2024: A 69-Year-Old Man with Dyspnea after Old Myocardial Infarction

The New England Journal of Medicine

OCTOBER 30, 2024

A 69-year-old man with a history of MI and cardiomyopathy presented with 2 days of dyspnea. Regular tachycardia (124 beats per min), diaphoresis, and rales were present. A diagnosis was made.

Myocardial Infarction

Myocardial Infarction Tachycardia Cardiomyopathy

Case Report: Fatal atrioesophageal fistula following atrial fibrillation ablation—critical reflections on prevention

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction. A 71-year-old male admitted to the emergency department on July 19, 2024, with acute loss of consciousness and convulsions.

Atrial Fibrillation

Atrial Fibrillation Ablation Cardiogenic Shock Myocardial Infarction

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients

Frontiers in Cardiovascular Medicine

APRIL 1, 2025

More than half of the patients presented with heart failure (n=2,234, 55.4%), followed by acute myocardial infarction (n=1,368, 34.0%), coronary artery disease (n=674, 16.7%), and acute coronary syndrome (n=164, 4.1%). The mean age ranged between 56 and 76 and 5873 years for depressed vs. non-depressed individuals respectively.

Biomarkers

Biomarkers Coronary Artery Disease Article Myocardial Infarction

Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients without Revascularization: China Acute Myocardial Infarction (CAMI) Registry Study

The American Journal of Cardiology

FEBRUARY 23, 2024

Publication date: Available online 23 February 2024 Source: The American Journal of Cardiology Author(s): Cunrong Huang, Jingang Yang, Ling Li, Shenghu He, Xuxia Zhang, Haiyan Xu, Yuan Wu, Jun Zhang, Shubin Qiao, Yongjian Wu, Yanyan Zhao, Yang Wang, Wei Li, Chen Jin, Xiaojin Gao, Yuejin Yang, CAMI (China Acute Myocardial Infarction) Registry Study (..)

Myocardial Infarction

Benefits of complete revascularization confirmed in older patients with ST-elevation myocardial infarction

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Myocardial Infarction

Myocardial Infarction STEMI Research

Role of autophagy in myocardial remodeling after myocardial infarction

Journal of Cardiovascular Pharmacology

OCTOBER 24, 2024

Myocardial remodeling is characterized by gradual heart enlargement, cardiac dysfunction, and extraordinary molecular changes. Cardiac remodeling after myocardial infarction is almost inevitable, which is the leading cause of heart failure. Autophagy has a protective effect on myocardial remodeling improvement.

Myocardial Infarction

Myocardial Infarction Heart Failure Ischemia Heart Disease

Navigating Early Management Strategies in Acute Myocardial Infarction With Cardiogenic Shock

The American Journal of Cardiology

JULY 24, 2024

Publication date: Available online 23 July 2024 Source: The American Journal of Cardiology Author(s): Kahtan Fadah, Helayna Abraham, Subhash Banerjee, Debabrata Mukherjee

Cardiogenic Shock

Cardiogenic Shock Myocardial Infarction

Chest pain: Are these really "Nonspecific ST-T wave abnormalities", as the cardiologist interpretation states?

Dr. Smith's ECG Blog

MAY 27, 2024

Int J Cardiol 2024 2. ST depression in lead AVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Ischemic ST-segment depression maximal in V1-4 (versus V5-6) of any amplitude is specific for occlusion myocardial infarction (versus nonocclusive ischemia). De Alencar Neto. Nikus et al.

Chest Pain

Chest Pain STEMI Myocardial Infarction Ischemia

Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction Undergoing Surgical Revascularization.

The American Journal of Cardiology

MAY 21, 2024

Publication date: Available online 20 May 2024 Source: The American Journal of Cardiology Author(s): Marsioleda Kemberi, Eduardo Urgesi, Ji ngYong Ng, Kush Patel, Mohammed Y Khanji, Wael I Awad

Myocardial Infarction

Myocardial Infarction Outcomes

Abstract 4146832: Cardiac Fibroblast Atlas Reveals Myofibroblast Activation After Myocardial Infarction

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146832-A4146832, November 12, 2024. Introduction:After a myocardial infarction (MI), cardiac fibroblasts are activated to deposit extracellular matrix that while prevents acute cardiac rupture in the short-term, causes long-term diastolic and systolic dysfunction.

Myocardial Infarction

Myocardial Infarction Circulation

Abstract 4135229: Endothelial glycocalyx shedding during ST-elevation acute myocardial infarction

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4135229-A4135229, November 12, 2024. eGC shedding could contribute to atherosclerotic plaque vulnerability and acute myocardial infarction (AMI) installation. eGC shedding could contribute to atherosclerotic plaque vulnerability and acute myocardial infarction (AMI) installation.

Myocardial Infarction

Myocardial Infarction Plaque Technology Diabetes

Epigastric and Right Upper Quadrant pain after eating spicy food

Dr. Smith's ECG Blog

AUGUST 26, 2024

Compared with: 8/18/2024 6:08 AM This time neither see acute MI. But the Queen of Hearts now sees it: Notice that the dark blue in this explainability map tells you that she also is seeing the short S-wave and the hyperacute T-wave!

Myocardial Infarction

Myocardial Infarction Critical Care Echocardiogram Ischemia

Higher Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation Noted After Spinal Cord Injury

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury. 2024 Feb 20;83(7):741-751. Am J Phys Med Rehabil. doi: 10.1097/PHM.0b013e31802f0247.

Myocardial Infarction

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure

Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Gema Miñana, Alberto Cordero, Lorenzo Fácila, Mireia Company, Agustín Fernández-Cisnal, Ernesto Valero, Arturo Carratalá, Jorge Navarro, Javier Torres Llergo, Rosa Fernández-Olmo, Almudena Castro, Vicent Bodi, Juan Sanchis, Julio Núñez

Myocardial Infarction

Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI Registry: Healthcare Utilization after Myocardial Infarction

The American Journal of Cardiology

SEPTEMBER 8, 2024

Publication date: Available online 7 September 2024 Source: The American Journal of Cardiology Author(s): Khawaja M. Talha, Kendall Hammonds, Ayman Alhamdow, Monica M. Bennett, J. Vee Anne Bomar, Jason A. Ettlinger, Monica Martinez-Traba, Elisabeth Sophia Hartgers-Gubbels, Elisa L. Priest, Courtney N. Shaver, Aasim Afzal, Robert J.

Myocardial Infarction

Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained

Circulation

SEPTEMBER 8, 2024

Circulation, Volume 150, Issue 11 , Page 836-837, September 10, 2024.

Myocardial Infarction

Myocardial Infarction Circulation

NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction

The New England Journal of Medicine

AUGUST 31, 2024

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 European Society of Cardiology annual meeting.

Myocardial Infarction

Myocardial Infarction Research

Abstract 4135252: Associations between Group 2 Pulmonary Hypertension and 30-Day Readmissions Following Acute Myocardial Infarction Hospitalizations.

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024. Background:Pulmonary hypertension (PH) is a major contributor to cardiovascular disease-related morbidity and mortality.

Myocardial Infarction

Myocardial Infarction Hospital Hypertension Pulmonary

Corrigendum to ‘Clinical Impact of Perfusion Balloon for ST-Segment Elevated Myocardial Infarction: RYUSEI Study’ [Am J Cardiol 223 (2024) start 23-51]

The American Journal of Cardiology

AUGUST 28, 2024

Publication date: Available online 28 August 2024 Source: The American Journal of Cardiology Author(s): Masami Nishino, Yasuyuki Egami, Hitoshi Nakamura, Masaru Abe, Mizuki Ohsuga, Hiroaki Nohara, Shodai Kawanami, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Masamichi Yano

Myocardial Infarction

BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

DAIC

JULY 17, 2024

mtaschetta-millane Wed, 07/17/2024 - 11:06 July 17, 2024 — BioCardia, Inc. , This design is intended to enable smooth navigation and prevent “whip,” when the build-up of mechanical forces in the device causes a catheter to suddenly jump from one orientation to another. This is an elegant solution to a long-standing technical issue.

Myocardial Infarction

Myocardial Infarction Atrial Fibrillation Technology Angina

NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction

The New England Journal of Medicine

NOVEMBER 16, 2024

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.

Myocardial Infarction

Myocardial Infarction Research

Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention

The American Journal of Cardiology

FEBRUARY 25, 2024

Publication date: Available online 24 February 2024 Source: The American Journal of Cardiology Author(s): Yousaf Abughofah, Wesley Anderson, Rolf P Kreutz

Myocardial Infarction

Myocardial Infarction Outcomes

Direct Oral Anticoagulants versus Vitamin K Antagonists for the Management of Left Ventricular Thrombus after Myocardial Infarction: A Meta-analysis

The American Journal of Cardiology

SEPTEMBER 11, 2024

Publication date: Available online 11 September 2024 Source: The American Journal of Cardiology Author(s): Christos Gogos, Vasileios Anastasiou, Andreas S.

Myocardial Infarction

Dynamic OMI ECG. Negative trops and negative angiogram does not rule out coronary ischemia or ACS.

Dr. Smith's ECG Blog

SEPTEMBER 18, 2024

Thus, it has recently become generally accepted that most plaque ruptures resulting in myocardial infarction occur in plaques that narrow the lumen diameter by 40% of the arterial cross section may be involved by plaque. This confirms that the pain was ischemia and is now resovled. The i nitial hs troponin I returned 75%.

Ischemia

Ischemia Plaque Stenosis Myocardial Infarction

Abstract 4139191: ETX-258 - A GalOmic™ siRNA for the Treatment of Heart Failure Following Myocardial Infarction

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139191-A4139191, November 12, 2024. These challenges highlight the need for new therapies that are both safe and effective in targeting the structural remodeling pivotal to disease progression post-myocardial infarction (MI).

Myocardial Infarction

Myocardial Infarction Heart Failure Cardiac Function Biomarkers

Small extracellular vesicles from the infarcted heart can promote tumour growth

Nature Reviews - Cardiology

APRIL 1, 2024

Nature Reviews Cardiology, Published online: 02 April 2024; doi:10.1038/s41569-024-01022-0 After myocardial infarction, the heart secretes small extracellular vesicles with pro-neoplastic properties that can accelerate tumour growth when taken up by cancer cells.

Myocardial Infarction

Myocardial Infarction Cancer

Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?

Nature Reviews - Cardiology

MAY 6, 2024

Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’.

Coronary Artery Disease

Coronary Artery Disease Myocardial Infarction Article Outcomes

Interferon response at the border zone of the infarcted heart

Nature Reviews - Cardiology

SEPTEMBER 16, 2024

Nature Reviews Cardiology, Published online: 17 September 2024; doi:10.1038/s41569-024-01078-y Cardiomyocytes can activate the type I interferon response in the infarct border zone after myocardial infarction, indicating that the type I interferon pathway, in addition to its well-established role in antiviral responses, is also involved in cardiac (..)

Myocardial Infarction

EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION

Journal of Cardiovascular Pharmacology

APRIL 4, 2024

Myocardial infarction (MI) and pulmonary artery hypertension (PAH) are two prevalent cardiovascular diseases. This study aims to evaluate the effect of PTE on oxidative stress in the hearts of animals with myocardial infarction and in the lungs of animals with PAH. Copyright © 2024 Wolters Kluwer Health, Inc.

Myocardial Infarction

Myocardial Infarction Cardiovascular Disease Pulmonary Hypertension

BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family

DAIC

JULY 31, 2024

mtaschetta-millane Wed, 07/31/2024 - 07:00 July 31, 2024 — BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath.

Myocardial Infarction

Myocardial Infarction Technology Angina Pulmonary

Acute Ascending Aortic Dissection Masquerading as a ST Elevation Myocardial Infarction

The American Journal of Cardiology

DECEMBER 18, 2024

Publication date: Available online 17 December 2024 Source: The American Journal of Cardiology Author(s): Ariane Lemieux, Helen Hashemi, Charles S. Roberts, Jeffrey M. Schussler

Myocardial Infarction

Myocardial Infarction Aortic

Abstract WP244: Myocardial Infarction Risk Following Stroke and Cervical Artery Dissection: Multi-State Inpatient Sample Analysis

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP244-AWP244, February 1, 2024. We utilized a multi-state database to examine myocardial infarction (MI) risk post stroke or CAD to estimate cardiovascular complication risk.Method:We analyzed State Inpatient Database from New York (2011-2017) and Florida (2011-2019).

Myocardial Infarction

Myocardial Infarction Inpatient Stroke Strokes

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

Image courtesy: ACC christine.book Thu, 02/29/2024 - 11:22 February 29, 2024 — The American College of Cardiology ( ACC ) will soon be holding its ACC 73rd Annual Scientific Session & Expo , ACC.24 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

NEJM at ESC — Beta Blocker Interruption or Continuation with Prior Myocardial Infarction

The New England Journal of Medicine

AUGUST 29, 2024

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 European Society of Cardiology annual meeting.

Myocardial Infarction

Myocardial Infarction Research

Pharmaco-Invasive Approach in Older Patients Presenting With ST-Segment–Elevation Myocardial Infarction

Circulation: Cardiovascular Interventions

DECEMBER 16, 2024

Circulation: Cardiovascular Interventions, Volume 17, Issue 12 , Page e014890, December 1, 2024.

Myocardial Infarction

Myocardial Infarction Cardiovascular Interventions Circulation

Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial

Circulation

JANUARY 21, 2024

Circulation, Volume 149, Issue 4 , Page 335-338, January 23, 2024.

Myocardial Infarction

Myocardial Infarction Pulmonary Circulation

Letter by ?uli? Regarding Article, “Extreme Temperature Events, Fine Particulate Matter, and Myocardial Infarction Mortality”

Circulation

JANUARY 7, 2024

Circulation, Volume 149, Issue 2 , Page 167-167, January 9, 2024.

Myocardial Infarction

Myocardial Infarction Article Circulation

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

DAIC

JUNE 25, 2024

Pocket-Sized Kardia 12L ECG System milla1cf Tue, 06/25/2024 - 18:55 June 25, 2024 — AliveCor , the global leader in AI -powered cardiology, today announced the U.S. Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System. million ECGs from leading US medical centers.

Technology

Technology Heart Attack Heart attacks Innovation

Clinical Impact of Perfusion Balloon for ST-segment Elevated Myocardial Infarction: RYUSEI Study

The American Journal of Cardiology

MAY 10, 2024

Publication date: Available online 10 May 2024 Source: The American Journal of Cardiology Author(s): Masami Nishino, Yasuyuki Egami, Hitoshi Nakamura, Masaru Abe, Mizuki Ohsuga, Hiroaki Nohara, Shodai Kawanami, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Masamichi Yano

Myocardial Infarction

Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart Attack

Heart Attack Heart attacks Risk Factors Research

Response by Frangogiannis to Letter Regarding Article, “Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction”

Circulation

MARCH 17, 2024

Circulation, Volume 149, Issue 12 , Page e962-e963, March 19, 2024.

Myocardial Infarction

Myocardial Infarction Article Circulation

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

Association between waist-to-hip ratio and risk of myocardial infarction: a systematic evaluation and meta-analysis

No benefit of apoA-I infusion after myocardial infarction

Webinars

Case 34-2024: A 69-Year-Old Man with Dyspnea after Old Myocardial Infarction

Case Report: Fatal atrioesophageal fistula following atrial fibrillation ablation—critical reflections on prevention

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients

Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients without Revascularization: China Acute Myocardial Infarction (CAMI) Registry Study

Benefits of complete revascularization confirmed in older patients with ST-elevation myocardial infarction

Role of autophagy in myocardial remodeling after myocardial infarction

Navigating Early Management Strategies in Acute Myocardial Infarction With Cardiogenic Shock

Chest pain: Are these really "Nonspecific ST-T wave abnormalities", as the cardiologist interpretation states?

Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction Undergoing Surgical Revascularization.

Abstract 4146832: Cardiac Fibroblast Atlas Reveals Myofibroblast Activation After Myocardial Infarction

Abstract 4135229: Endothelial glycocalyx shedding during ST-elevation acute myocardial infarction

Epigastric and Right Upper Quadrant pain after eating spicy food

Higher Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation Noted After Spinal Cord Injury

Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction

Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI Registry: Healthcare Utilization after Myocardial Infarction

Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained

NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction

Abstract 4135252: Associations between Group 2 Pulmonary Hypertension and 30-Day Readmissions Following Acute Myocardial Infarction Hospitalizations.

Corrigendum to ‘Clinical Impact of Perfusion Balloon for ST-Segment Elevated Myocardial Infarction: RYUSEI Study’ [Am J Cardiol 223 (2024) start 23-51]

BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction

Renal Dysfunction and Outcomes in Patients With ST-Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention

Direct Oral Anticoagulants versus Vitamin K Antagonists for the Management of Left Ventricular Thrombus after Myocardial Infarction: A Meta-analysis

Dynamic OMI ECG. Negative trops and negative angiogram does not rule out coronary ischemia or ACS.

Abstract 4139191: ETX-258 - A GalOmic™ siRNA for the Treatment of Heart Failure Following Myocardial Infarction

Small extracellular vesicles from the infarcted heart can promote tumour growth

Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?

Interferon response at the border zone of the infarcted heart

EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION

BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family

Acute Ascending Aortic Dissection Masquerading as a ST Elevation Myocardial Infarction

Abstract WP244: Myocardial Infarction Risk Following Stroke and Cervical Artery Dissection: Multi-State Inpatient Sample Analysis

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

NEJM at ESC — Beta Blocker Interruption or Continuation with Prior Myocardial Infarction

Pharmaco-Invasive Approach in Older Patients Presenting With ST-Segment–Elevation Myocardial Infarction

Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial

Letter by ?uli? Regarding Article, “Extreme Temperature Events, Fine Particulate Matter, and Myocardial Infarction Mortality”

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

Clinical Impact of Perfusion Balloon for ST-segment Elevated Myocardial Infarction: RYUSEI Study

Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

Response by Frangogiannis to Letter Regarding Article, “Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction”

Stay Connected